Theravance Biopharma TBPH
NASDAQ TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) EV to CFO (2025 - 2026)

Updated

Theravance Biopharma's EV to CFO was 9.20 in Q2 2026, up 940.5% from 0.88 a year earlier and up 460.3% from the prior quarter.

Analysis

Theravance Biopharma (TBPH) EV to CFO (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Theravance Biopharma's EV to CFO was -10.15 through Jun 30, 2026; for FY2025, it came in at 2.68.

  • The Q2 2026 figure marks the highest quarterly EV to CFO since Q1 2025.
  • Per Business Quant data, TBPH's EV to CFO in the three quarters before Q2 2026 was 1.64 (Q1 2026), 2.68 (Q4 2025) and 1.68 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Theravance Biopharma 883.70 Mn -543.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.20
Mar 31, 2026 1.64
Dec 31, 2025 2.68
Sep 30, 2025 1.68
Jun 30, 2025 0.88
Mar 31, 2025 9.70
API Access

Theravance Biopharma EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=TBPH&period=max&api_key=YOUR_API_KEY